10-hydroxy-2-decenoic acid has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, S; Fukamachi, K; Iinuma, M; Matsumoto, H; Suzui, M; Yoshimoto, E | 1 |
| Chou, WM; Lin, IP; Peng, CC; Widowati, DA; Yang, YC | 1 |
2 other study(ies) available for 10-hydroxy-2-decenoic acid and Colonic Neoplasms
| Article | Year |
|---|---|
Palmitoyl piperidinopiperidine, a novel derivative of 10‑hydroxy‑2‑decenoic acid, as a potent and selective anticancer agent against human colon carcinoma cell lines.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azoxymethane; Carcinogens; Carcinoma; Cell Line, Tumor; Chick Embryo; Chorioallantoic Membrane; Colonic Neoplasms; Fatty Acids, Monounsaturated; Female; Humans; Inhibitory Concentration 50; Male; Mice; Molecular Docking Simulation; Neoplasms, Experimental; Neovascularization, Pathologic; Rats; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2021 |
10-hydroxy-2-decenoic acid of royal jelly exhibits bactericide and anti-inflammatory activity in human colon cancer cells.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacteria; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cytokines; Fatty Acids; Fatty Acids, Monounsaturated; Humans | 2018 |